PD-L1 Expression in Untreated EGFR-Mutated Advanced NSCLC and Response to Osimertinib
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Thoracic Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Programmed Cell Death Ligand 1 Expression in Untreated EGFR Mutated Advanced NSCLC and Response to Osimertinib Versus Comparator in FLAURA
J Thorac Oncol 2020 Jan 01;15(1)138-143, H Brown, J Vansteenkiste, K Nakagawa, M Cobo, T John, C Barker, A Kohlmann, A Todd, M Saggese, J Chmielecki, A Markovets, M Scott, SS RamalingamFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.